Centessa Pharmaceuticals Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Centessa Pharmaceuticals's estimated annual revenue is currently $7.5M per year.(i)
Centessa Pharmaceuticals's estimated revenue per employee is $90,361
Centessa Pharmaceuticals's current valuation is $801M. (January 2022)

Name	Title	Email/Phone
1 Phil Perera	Clinical Consultant and Consulting Chief Medical Officer	Reveal Email/Phone
2 John Crowley	Chief Financial Officer	Reveal Email/Phone
3 Stephen Kanes	Chief Medical Officer	Reveal Email/Phone
4 John Crowley	Chief Financial Officer	Reveal Email/Phone
5 Henry Wolfe	SVP, Biologics CMC	Reveal Email/Phone
6 Matt Bigert	VP, CMC & Analytical R&D	Reveal Email/Phone
7 Kerstin Schultz	VP, Global Team Leader	Reveal Email/Phone
8 Courtney. Bryant	VP, Clinical Development Operations	Reveal Email/Phone
9 Milena Kanova	VP, Global Clinical Operations	Reveal Email/Phone
10 Iqbal Hussain	General Counsel	Reveal Email/Phone

keywords:N/A

N/A

Total Funding

Number of Employees

$7.5M

Revenue (est)

Employee Growth %

$801M

Valuation

N/A

Accelerator

Centessa Pharmaceuticals (NASDAQ:CNTA) Upgraded by Zacks Investment Research to Hold. Posted by admin on Apr 26th, 2022.

According to Zacks, Centessa Pharmaceuticals plc is a clinical-stage company employing its innovative asset-centric business model to discover,...

Centessa Pharmaceuticals plc (Centessa) is a clinical-stage pharmaceutical company with a Research & Development (R&D) innovation engine...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Horizon Academy	$14.4M	83	26%	N/A
#2 Saint Arnold Br...	$28.4M	83	5%	N/A
#3 Urban Behavior	$23.4M	83	1%	N/A
#4 Alliance SI	$19.8M	83	9%	N/A
#5 PORT WASHINGTON...	$19.5M	83	0%	N/A